1. Simulation-Based Education for Physicians to Increase Oral Anticoagulants in Hospitalized Elderly Patients with Atrial Fibrillation
- Author
-
Franchi, C, Antoniazzi, S, Ardoino, I, Proietti, M, Marcucci, M, Santalucia, P, Monzani, V, Mannucci, Pm, Nobili, A, Bosari, S, Brignoto, B, Nicolis, E, Fenoglio, Lm, Melchio, R, Fabris, F, Sartori, Mt, Manfredini, R, De Giorgi, A, Fabbian, F, Biolo, G, Zanetti, M, Altamura, N, Sabba, C, Suppressa, P, Bandiera, F, Usai, CINZIA PATRIZIA, Murialdo, G, Fezza, Fabrizio, Marra, A, Castelli, F, Cattaneo, F, Beccati, V, di Minno, G, Tufano, A, Contaldi, P, Lupattelli, G, Bianconi, V, Cappellini, D, Hu, C, Minonzio, F, Fargion, S, Burdick, L, Francione, P, Peyvandi, F, Rossio, R, Colombo, Gherardo, Ceriani, G, Lucchi, T, Brignolo, B, Manfellotto, D, Caridi, I, Corazza, Gr, Miceli, E, Padula, D, Fraternale, G, Guasti, L, Squizzato, A, Maresca, A, Liberato, Nl, Tognin, T, Rozzini, R, Bellucci, Fb, Muscaritoli, M, Molfino, A, Petrillo, E, Dore, M, Raviolo, P, Mete, F, Gino, M, Franceschi, F, Gabrielli, M, Perticone, F, Perticone, M, Bertolotti, M, Mussi, C, Borghi, C, Strocchi, E, Durazzo, M, Fornengo, P, Ruatta, C, Dallegri, F, Ottonello, Lc, Salam, K, Caserza, L, Barbagallo, M, Di Bella, G, Annoni, G, Bruni, Aa, Odetti, P, Nencioni, A, Monacelli, F, Napolitano, A, Brucato, A, Valenti, A, Castellino, P, Zanoli, L, and Mazzeo, M
- Subjects
Male ,medicine.medical_specialty ,Cluster randomized trial ,Socio-culturale ,Administration, Oral ,030204 cardiovascular system & hematology ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine and geriatric wards ,Intervention (counseling) ,Hospital discharge ,medicine ,Odds Ratio ,Cluster Analysis ,Humans ,030212 general & internal medicine ,Cluster randomised controlled trial ,Medical prescription ,Simulation based ,Simulation Training ,Simulation-based education ,LS4_7 ,Aged ,Aged, 80 and over ,business.industry ,Anticoagulants ,Atrial fibrillation ,General Medicine ,Odds ratio ,medicine.disease ,Older people ,Oral anticoagulants ,SIM-AF trial ,Confidence interval ,Atrial fibrillation, Cluster randomized trial, Internal medicine and geriatric wards, Older people, Oral anticoagulants, SIM-AF trial, Simulation-based education ,Patient Simulation ,Stroke ,Geriatrics ,Emergency medicine ,Education, Medical, Continuing ,Female ,Clinical Competence ,business - Abstract
Purpose This study was intended to determine whether a simulation-based education addressed to physicians was able to increase the proportion of hospitalized elderly with atrial fibrillation prescribed with oral anticoagulants (OACs) compared with the usual practice. Methods We conducted a cluster randomized trial (from April 2015 to September 2018) on 32 Italian internal medicine and geriatric wards randomized 1:1 to intervention or control arms. The physicians of wards randomized to intervention received a computer-based e-learning tool with clinical scenarios (Dr Sim), and those of wards randomized to control received no formal educational intervention. The primary outcome was the OAC prescription rate at hospital discharge in the intervention and control arms. Results Of 452 patients scrutinized, 247 were included in the analysis. Of them, 186 (75.3%) were prescribed with OACs at hospital discharge. No difference was found between the intervention and control arms in the post-intervention phase (odds ratio, 1.46; 95% confidence interval [CI], 0.81-2.64). The differences from the pre- to post-intervention phases in the proportions of patients prescribed with OACs (15.1%; 95% CI, 0%-31.5%) and with direct oral anticoagulants (DOACs) (20%; 95% CI, 0%-39.8%) increased more in the intervention than in the control arm. Conclusions This simulation-based course did not succeed in increasing the rate of elderly patients prescribed with OACs at hospital discharge compared with the usual practice. Notwithstanding, over time there was a greater increase in the intervention than in the control arm in the proportion of patients prescribed with OACs and DOACs. Trial Registration ClinicalTrials.gov identifier: NCT03188211.
- Published
- 2019